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Abstract
The aim of this study is to analyze amino acid plasma profile in a group of young
diabetics and to evaluate its application as markers of metabolic control of the disease,
as well as to analyze the urinary excretion of amino acids in these patients. A clinical
assessment and metabolic study (amino acid serum concentrations and urinary excre-
tion of amino acids) was accomplished in a group of 49 children diagnosed with diabe-
tes, and a group of 48 healthy children (control group). The plasma levels of total amino
acids as well as branchedchain, glucogenic and ketogenic amino acids were significantly
higher (p < 0.05) in the diabetic group with respect to the control group. Total as well as
branched-chain, glucogenic and ketogenic amino acids urinary levels were significantly
lower (p < 0.05) in the diabetic group compared to the control group. The study of the
amino acid plasma in the young diabetic reflect disturbances in protein/amino acid
metabolism and, consequently, in metabolic control of the disease. The study of amino
acid urinary excretion might have interest not only in the context of diabetic nephropa-
thy, but also in the revealing of partial aspects of amino acid metabolism and, probably,
in the metabolic control of the disease.
Keywords: amino acids, insulin-dependent diabetes mellitus, children, serum
concentration, urinary excretion
1. Introduction
Most of the cells in our body are dependent on the anabolic effects of insulin, which enables the
use and storage of different nutrients from the diet.
© 2018 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
It has been experimentally proven that insulin deficiency involves a series of ultrastructural
and/or functional changes at an intracellular level, within muscle as well as liver, which
substantially inhibit protein synthesis and stimulate protein degradation. Therefore, being
amino acidosis, the structural elements of proteins and its metabolism could be altered in
diabetes mellitus [1, 2]. In fact, significant changes in amino acid plasma levels and urinary
excretion have been described in diabetic ketoacidosis, as well as anomalies in postprandial
plasma profile of such amino acids in diabetic patients, whose values will not even return to
normal levels after intensive insulin therapy [3–6].
Diabetic nephropathy is one of the most frequent and severe late complications in infant-
juvenile diabetes; its functional and structural pathology seems to be shaped from the early
stages of the disease. Persistent microalbuminuria is a functional disruption that occurs in the
emerging phases of diabetic nephropathy, whose early detection and monitoring is quite
important due to its prognostic significance [7, 8].
An increased urinary excretion of low molecular weight proteins and lysosomal enzymes has
been confirmed in diabetic patients in the absence of microalbuminuria, as a result of a
disorder in renal tubular reabsorption; its significance in natural history of diabetic nephropa-
thy would be interpreted as early markers of renal injury [9–11]. On the other hand, barely 2–
3% of the total amount of amino acidosis filtered by the glomerulus is excreted in urine
following a massive and active tubular reabsorption [12]. Hence, aminoaciduria in diabetic
individuals might be conditioned by the degree of structural and/or functional integrity of the
renal tubule.
The aim of this study is to analyze amino acid plasma profile in a group of young diabetic
individuals and to evaluate its potential application as markers of metabolic control of the
disease, as well as to analyze the urinary excretion of amino acids in the absence of
microalbuminuria in these patients.
2. Material and methods
2.1. Participants
A clinical assessment and metabolic study was accomplished in 49 children diagnosed with
insulin-dependent diabetes mellitus, aged 8.6–14.3 years, following conventional insulin ther-
apy, and a group of 48 healthy children (control group) aged 7.4–14.8 years.
2.2. Clinical assessment
Information recorded from every patient/participant included age, weight and height, BMI,
time and progress of the disease, and dosage of subcutaneous insulin.
Weight and height measurements were made in underwear while being barefoot. Weight was
measured using the Año-Sayol scale (reading interval 0–120 kg and a precision of 100 g), and
height was measured using the Holtain wall stadiometer (reading interval 60–210 cm, preci-
sion 0.1 cm). The Z-score values for the BMI were calculated using the epidemiologic data
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contained within the program Aplicación Nutricional, from the Spanish Society of pediatric
gastroenterology, hepatology, and nutrition (Sociedad Española de Gastroenterología,
Hepatología y Nutrición Pediátrica, available at http://www.gastroinf.es/nutritional/). The
graphics from Ferrández et al. (Centro Andrea Prader, Zaragoza) (2002) were used as reference
charts.
Blood pressure (BP) was measured in the right arm with the patient in the supine position
using Visomat comfort 20/40 (Roche Diagnostics Inc.) digital blood pressure monitor, record-
ing the lowest of three measurements.
2.3. Biochemical analysis
All participants (diabetic and control group) underwent blood testing after a 12-hour fast, in
order to determine plasma glucose levels, glycosylated hemoglobin (Hb1Ac), creatinine and
amino acid concentrations. In addition, a 24-hour urine sample was collected to determine
albumin and amino acid concentrations and glomerular filtration rate (GFR).
The analyzed amino acids (in blood and urine) were the following: alanine (ALA), arginine
(ARG), aspartic acid (ASP), cysteine (CYS), glutamine (GLN), glutamic acid (GLU), glycine
(GLY), histidine (HIS), isolecucine (ILE), leucine (LEU), lisine (LYS), methionine (MET), phe-
nylalanine (PHE), serine (SER), threonine (THR), tyrosine (TYR), valine (VAL), and taurine
(TAU).
Measurements in plasma (glucose and creatinine) and urine (creatinine) were made using a
Synchron CX5 (Beckman) analyzer. HbA1c was determined using Boehringer-Mannheim
reagents.
The quantification of urinary albumin excretion (UAE) was made by nephelometry (Away
Protein System-Beckman), and microalbuminuria was considered when values exceed 12 ug/
min, being that a reason for exclusion. GFR was calculated using the endogenous creatinine
clearance, and hyperfiltration was considered when values were over 145 ml/min/11.73 m2.
The determination of urine and plasma amino acid concentrations was made by reversed-
phase high pressure liquid chromatography (HPLC) with o-phthaldialdehyde precolumn
derivatization.
2.4. Statistical analysis
Results are displayed as means (M) with corresponding standard deviations (SD). Statistical
analysis (descriptive statistics, Student’s T and Pearson’s correlation) was done using the
Statistical Packages for the Social Sciences version 20.0 (Chicago, IL, USA). Statistical signifi-
cance was assumed when p value was lower than 0.05.
Parents and/or legal guardians were informed and provided verbal consent for the participa-
tion in this study in all cases. The study was approved by the Ethics Committee for Human
Investigation at our institution (in accordance with the ethical standards laid down in the 1964
Declaration of Helsinki and later amendments).
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3. Results
Table 1 shows the comparison of mean values for the clinical and biochemical characteristics
(blood and urine) in the diabetic and control groups. Fasting glycaemia, Hb1Ac, and GFR were
significantly higher (p < 0.05) within the diabetic group compared to the control group. There
were not any significant differences in age, BMI Z-score, systolic and diastolic blood pressure,
and urinary albumin excretion between both groups.
There was no correlation between glomerular filtration and Hb1Ac or urinary albumin excre-
tion, not between blood pressure (systolic and diastolic blood pressure) and glomerular filtra-
tion or Hb1Ac. There was a positive correlation (p < 0.05) between diastolic blood pressure and
the evolution of the disease (years) (r = 0.515).
Table 2 exposes and compares the mean values of amino acid plasma concentrations for the
samples of the diabetic and control groups. Plasma concentrations of ARG, GLN, ILE, PHE,
THR, TYR, VAL, and TAU were significantly higher (p < 0.05) within the diabetic group with
respect to the control group.
Table 3 depicts and compares the mean values of plasma concentrations of different amino
acids groups analyzed in the diabetic and control group. The plasma levels of total amino acids
as well as branched-chain, glucogenic, and ketogenic amino acids were significantly higher
(p < 0.05) in the diabetic group with respect to the control group.
There was no correlation between the single amino acid (or amino acid groups) plasma levels
and the evolution of the disease (years) or Hb1Ac. There was a negative correlation (p < 0.05)
among insulin dosage and amino acids THR (r = 0.404), MET (r = 0.513), PHE (r = 0.456),
SER (r =  0.442), CYS (r = 0.390), GLY (r = 0.451), and TAU (r = 0.479), as well as a
Items Diabetic group
(n = 49)
Control group
(n = 48)
p-Values
Age (years) 11.82  1.78 12.05  1.93 n.s.
BMI Z-score 0.05  0.67 0.01  0.55 n.s.
Systolic BP 93.15  8.85 89.0  8.95 n.s.
Diastolic BP 55.0  7.26 52.2  8.36 n.s.
Evolution (years) 5.79  2.67 — —
Insulin (UI/kg/d) 0.82  0.26 — —
Glucose (mg(dl)) 198.8  55.5 89.57  10.2 <0.01
Hb1Ac (%) 7.7  1.68 4.56  0.7 <0.05
GFR (ml/min/1.73 m2) 135.65  34.3 114.16  9.13 <0.05
UAE (ug/min) 3.77  1.8 3.42  1.89 n.s.
GFR: glomerular filtration rate, UAE: urinary albumin excretion.
Table 1. Clinical and biochemical characteristics of the diabetic and control groups (M  SD).
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positive correlation (p < 0.05) among glycaemia and amino acids VAL (r = 0.545) and LEU
(r = 0.648).
Table 4 displays and compares the mean values of urinary concentrations of different amino
acids quantified in the diabetic and control group. The urinary level of amino acids, except for
ASP, ILE, and PHE, was significantly lower (p < 0.05) in the diabetic group with respect to the
control group.
Table 5 outlines and compares the mean values of urinary levels of the different amino acids
groups in the diabetic and control group. Total as well as branched-chain, glucogenic and
ketogenic amino acid urinary levels were significantly lower (p < 0.05) in the diabetic group
compared to the control group. The mean values of the glucogenic/total amino acid ratio were
significantly lower (p < 0.05) in the diabetic group with respect to the control group. There
were no significant differences in the ketogenic/total amino acid ratio between both groups.
Amino acids Diabetic group
(n = 49)
Control group
(n = 48)
p-Values
ALA
ARG
ASP
CYS
GLN
GLU
GLY
HIS
ILE
LEU
LYS
MET
PHE
SER
THR
TYR
VAL
TAU
144.83  36.32
49.01  16.78
0.33  0.95
34.77  11.61
243.23  59.42
18.28  9.69
46.53  22.3
133.62  43.59
90.83  19.37
74.74  17.37
60.70  27.32
31.57  10.68
81.84  19.54
53.93  26.03
73.26  27.90
60.25  27.18
190.46  48.01
99.69  36.82
134.84  36.67
22.62  6.94
1.34  2.18
31.56  10.90
187.84  56.83
20.70  10.22
35.34  10.23
147.09  53.89
66.54  15.27
68.65  14.65
57.15  28.61
29.18  13.05
65.64  16.45
66.04  22.04
57.90  18.07
38.25  12.47
148.91  35.31
75.66  37.01
n.s.
<0.01
n.s.
n.s.
<0.01
n.s.
n.s.
n.s.
<0.001
n.s.
n.s.
n.s.
<0.01
n.s.
<0.05
<0.05
<0.01
<0.05
ALA: alanine, ARG: arginine, ASP: aspartic acid, CYS: cysteine, GLN: glutamine, GLU: glutamic acid, GLY: glycine, HIS:
histidine, ILE: isolecucine, LEU: leucine, LYS: lisine, MET: methionine, PHE: phenylalanine, SER serine, THR: threonine,
TYR tyrosine, VAL: valine, TAU: taurine.
Table 2. Plasma concentrations of amino acids (nmol/ml) in the diabetic and control groups (M  SD).
Amino acid groups Diabetic group
(n = 49)
Control group
(n = 48)
p-Values
Total 1383.70  353.67 1198.46  261.16 <0.05
Branched-chain 347.65  58.76 285.20  45.20 <0.01
Glucogenic 1252.74  236.82 1053.69  211.19 <0.001
Ketogenic 441.62  57.09 354.13  53.45 <0.05
Table 3. Plasma concentrations of amino acids (nmol/ml) in the diabetic and control groups (M  SD).
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There was no correlation between the levels of each particular amino acid and/or group of
amino acids in urine and the time of evolution, Hb1Ac, urinary albumin excretion, GFR, and
blood pressure (systolic and diastolic blood pressure).
4. Discussion
4.1. Plasma concentrations
In diabetes mellitus, the deficiency in insulin, and in large part, the effects of the counter
regulatory hormones would stimulate the synthesis of glucose—other than the glycogenolysis
Amino acids Diabetic group
(n = 49)
Control group
(n = 48)
p-Values
ALA
ARG
ASP
CYS
GLN
GLU
GLY
HIS
ILE
LEU
LYS
MET
PHE
SER
THR
TYR
VAL
TAU
53.97  36.68
2.45  1.91
4.98  3.23
19.25  11.07
7.84  4.52
16.62  9.61
23.00  15.05
74.12  48.50
18.98  10.31
12.46  8.17
223.65  150.75
19.11  8.01
40.64  22.58
10.64  7.64
14.47  10.96
26.65  16.28
25.61  11.94
115.17  56.70
118.07  45.24
4.59  2.97
8.84  4.22
61.91  29.17
95.02  32.18
35.83  15.77
192.41  121.59
233.95  89.36
29.83  18.42
22.16  9.13
525.32  196.31
86.04  56.06
51.67  13.71
25.40  13.65
63.29  19.36
79.08  21.15
45.11  13.67
172.31  107.12
<0.001
<0.05
n.s.
<0.05
<0.001
<0.05
<0.001
<0.01
n.s.
<0.05
<0.05
<0.05
n.s.
<0.01
<0.05
<0.001
<0.05
<0.01
ALA: alanine, ARG: arginine, ASP: aspartic acid, CYS: cysteine, GLN: glutamine, GLU: glutamic acid, GLY: glycine, HIS:
histidine, ILE: isolecucine, LEU: leucine, LYS: lisine, MET: methionine, PHE: phenylalanine, SER serine, THR: threonine,
TYR tyrosine, VAL: valine, TAU: taurine.
Table 4. Urinary levels of amino acids (μmol/m2) in the diabetic and control groups (M  SD).
Amino acid groups Diabetic group
(n = 49)
Control group
(n = 48)
p-Values
Total 754.94  427.16 1868.42  662.36 <0.05
Branched-chain 54.58  26.51 101.13  36.76 <0.05
Glucogenic 252.51  178.75 943.79  370.50 <0.05
Ketogenic 236.40  121.16 530.69  215.78 <0.05
Ratio G/T 0.34  0.09 0.50  0.07 <0.05
Ratio K/T 0.33  0.16 0.28  0.12 n.s.
G/T: glucogenic/total, K/T: ketogenic/total.
Table 5. Urinary level of amino acid groups in the diabetic and control groups (M  SD).
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pathway—through the glyconeogenesis [1, 2, 13]. This might explain the differences found in
the amino acid plasma levels within the diabetic and control group that, in general, would
indicate that there is an increase in the bioavailability of glycogenic substrates in diabetic
patients, even in basal conditions.
Insulin leads to a decrease in amino acid plasma levels through the stimulus of protein
synthesis and the inhibition of proteolysis [2, 14]; this would largely explain the negative
correlation found between insulin dosage and plasma level of the different amino acids.
Therefore, the significantly high plasma concentrations of the different amino acids–particu-
larly glucogenic amino acids–in the diabetic group with respect to the control group (probably
as a consequence of the insulinopenia that characterizes diabetes), could be useful as plasma
markers of a deficient metabolic control.
An increase in postprandial branched-chain amino acid (valine, leucine, and isoleucine)
plasma concentrations has been described in diabetic patients, in relation to the metabolic
control of the disease [4, 15]. This is probably due to a deficient peripheral metabolism of
these amino acids (they undergo basically muscle metabolism). Since it has not been
possible to prove an increase in the release of branched-chain amino acids from muscle
and/or liver in diabetic patients during fasting [1, 2], and being conscious that biological
effects of insulin are deficient in diabetes, it can be assumed that the increased branched-
chain amino acid plasma levels in the diabetic group in comparison to the control group
would be due to a low stimulation (by insulin) in amino acid transportation inside the
cell. Even though no correlation has been found between branched-chain amino acids
and metabolic control or time of evolution of diabetes, a positive correlation has been
detected between valine and leucine and fasting glycaemia, a fact that would support the
hypothesis of a more intense relationship among basal plasma concentration of these
amino acids and single determination glycaemia rather than with mediumterm metabolic
control.
Even though amino acids are appropriate substrates for hepatic and/or renal synthesis of glucose
(gluconeogenesis), glutamine and especially alanine are the most important glucogenic amino
acids in quantitative terms [16]. However, while glutamine plasma levels in basal conditions
were significantly higher in the diabetic group in comparison to control group, alanine plasma
levels did not differ in those groups.
During fasting, alanine release does not exclusively correspond to a mechanism of proteolysis
and posits muscle synthesis of new molecules of alanine from the glucose captured by the
muscle or glucose alanine cycle [2, 16]. Nevertheless, since glucose uptake by the muscle is
lowered due to insulinopenia in the diabetic patient, the conversion of glucose into alanine
would be decreased, and consequently, this would explain why alanine plasma levels in the
diabetic group do not differ from the control group.
Amino acid metabolism in insulin-dependent diabetes mellitus appears to be intrinsically
disrupted, since insulin deficiency and to a great extent, the effects of the counter regulatory
hormones imply an increase in hepatic gluconeogenesis and muscle proteolysis, as well as a
deficient peripheral use and/or disturbance in hepatic amino acid metabolism; this would
result in a plasma profile characterized by an increase of total amino acids, at the expense
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mainly of branched-chain and glucogenic amino acids. In this way, the study of the amino
acid plasma profile in diabetic patients would be worthwhile, since it would reflect distur-
bances in protein and/or amino acid metabolism and consequently, in metabolic control of
the disease.
4.2. Urinary excretion
Diabetic nephropathy is preceded by a window period, which might show different renal
functional and/or structural disturbances, even in the early stages of the disease [7, 8]. In
fact, the results obtained, in line with other researchers [17, 18], reveal significantly higher
glomerular filtration in the diabetic group in comparison to the control group, and especially
in those patients with a shorter period of disease and regardless of metabolic control of the
disease. In addition, even when the whole diabetic group had normal blood pressure mea-
surements, the existing correlation between diastolic blood pressure and the time of evolu-
tion of the disease suggests a situation of window period in diabetic nephropathy in this
group of young diabetics, and highlights the importance of periodic blood pressure mea-
surements in diabetics from the early stages of the disease. This allows for the beginning of a
dietary and/or medical treatment earlier than was recommended until now [19]. However, it
can be concluded that the structural integrity of the glomerulus in these diabetic patients
would be relatively well preserved, since the urinary excretion of albumin was similar in
both groups.
On another note, several researchers have noted a higher beta 2 microglobulin and lysosomal
enzyme urinary excretion in diabetic patients in the absence of microalbuminuria, as a sign of
functional disorder in the proximal tubule with no glomerular lesion, from the early stages of
the disease [10, 11]. In this context, the study of amino acid urinary excretion in the diabetic
could be of great interest, since different mechanisms of specific tubular reabsorption for
different amino acids have been described on an experimental basis [20]. Hence, any tubular
malfunction might condition significant qualitative and/or quantitative aminoaciduria, and
therefore, it could have a potential clinical application in the early detection of tubular lesion
and/or silent diabetic nephropathy.
All the same, and according to the results obtained, urinary excretion of each single amino
acid (except for isoleucine, aspartic acid, and taurine), as well as each amino acid groups
analyzed were significantly lower in the diabetic group with respect to the control group.
This may seem paradoxical; however, the difference observed in the relation glucogenic and
total amino acid (G/T ratio) between both groups reveals that the lower amino acid urinary
excretion in the diabetic would greatly be at the expense of glucogenic amino acids, proba-
bly because the glomerular filtration is also lower, as a consequence of a greater organic use
of these amino acids in the endogenous synthesis of glucose. No correlation has been found
between aminoaciduria and time of evolution, glomerular filtration, blood pressure, and
metabolic control.
In sum, the study of amino acid urinary excretion in the young diabetic might have interest not
only in the context of diabetic nephropathy, but also in the revealing of partial aspects of amino
acid metabolism, and probably, in the metabolic control of the disease.
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